Trials / Completed
CompletedNCT01644487
Self-Expanding Nitinol Stent Versus Balloon Angioplasty Alone for the Below The Knee Arteries(SENS-BTK)
Efficacy of Self-Expanding Nitinol Stent Versus Balloon Angioplasty Alone for the Below The Knee Arteries Following Successful Balloon Angioplasty Trial (Korean Vascular Intervention Multicenter Study)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 122 (actual)
- Sponsor
- Korea University Guro Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are to compare directly conventional balloon angioplasty alone versus. balloon angioplasty with routine stenting - that is, to determine whether angioplasty with self-expanding stent is superior to conventional balloon angioplasty - in the infrapopliteal arterial occlusive lesions of critical limb ischemia patients by collecting and analyzing the cases of each patient group in a prospective multicenter randomized clinical trial, and to clarify main factors affecting mid- and long-term clinical effects of angioplasty with self-expanding stent in the infrapopliteal arteries. Hypothesis: Balloon PTA followed by routine stenting with self-expanding nitinol stent in critical limb ischemia patients with infrapopliteal arterial occlusive lesions is superior to conventional PTA in the aspect of vascular restenosis rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | self-expanding nitinol stent | A group of patients who will undergo subsequent primary stenting following successful conventional balloon angioplasty |
| DEVICE | balloon angioplasty | A group of patients who will undergo routine conventional balloon angioplasty alone without stenting |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2016-09-06
- Completion
- 2018-10-10
- First posted
- 2012-07-19
- Last updated
- 2019-08-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01644487. Inclusion in this directory is not an endorsement.